This impaired PPARγ expression resulting from its suppression by TGF-β and related cytokines might contribute to unregulated fibroblast activation and persistent fibrogenesis and represent an important advance in understanding the pathophysiology of SSc. Here, PPARG is linked to systemic sclerosis.